← back to search

Tanja Eichkorn

Heidelberg University · DE
Area of research
Pulmonary and Respiratory Medicine · Genetics
Research interest
Research interests include Brain Metastases and Treatment, Glioma Diagnosis and Treatment, Advanced Radiotherapy Techniques, and Radiation Therapy and Dosimetry.
h-index
13
citations
442
works
67
NIH funding
primary concept
email

Recent publications

Hypofractionated stereotactic radiotherapy versus whole-brain radiotherapy following brain metastasis resection: Results of the ESTRON randomized phase 2 trial
Neuro-Oncology 2025cited by 3position: middledoi
Postoperative radiotherapy in subtotally resected recurrent WHO grade 1 meningiomas with intermediate-/high-risk molecular profiles
Neuro-Oncology 2025cited by 2position: middledoi
Repeat surgery of recurrent glioma for molecularly informed treatment in the age of precision oncology: A risk–benefit analysis
Journal of Neuro-Oncology 2024cited by 11position: middledoi
Radiation-Induced Cerebral Contrast Enhancements Strongly Share Ischemic Stroke Risk Factors
International Journal of Radiation Oncology*Biology*Physics 2024cited by 6position: firstdoi
Fractionated stereotactic radiotherapy of intracranial postoperative cavities after resection of brain metastases – Clinical outcome and prognostic factors
Clinical and Translational Radiation Oncology 2024cited by 6position: middledoi
Efficacy and toxicity of photon, proton, and carbon ion radiotherapy in the treatment of intracranial solitary fibrous tumor/hemangiopericytoma
Radiation Oncology 2024cited by 5position: middledoi
Understanding Relative Biological Effectiveness and Clinical Outcome of Prostate Cancer Therapy Using Particle Irradiation: Analysis of Tumor Control Probability With the Modified Microdosimetric Kinetic Model
International Journal of Radiation Oncology*Biology*Physics 2024cited by 3position: middledoi
Clinical Outcomes of Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Adrenal Metastases from a Single Institution
Cancers 2024cited by 2position: middledoi
Plasma extracellular vesicles in meningioma patients following radiotherapy as liquid biopsy- a prospective explorative biomarker study (ARO 2023-05/AG-NRO-07)
BMC Cancer 2024cited by 2position: middledoi
Analysis of safety and efficacy of proton radiotherapy for optic nerve sheath meningioma
Neuro-Oncology Advances 2024cited by 1position: middledoi
Fractionated stereotactic radiotherapy of brainstem metastases – Clinical outcome and prognostic factors
Clinical and Translational Radiation Oncology 2024cited by 1position: middledoi
To fly or not to fly: Stereotactic MR-guided adaptive radiotherapy effectively treats ultracentral lung tumors with favorable long-term outcomes
Lung Cancer 2023cited by 18position: middledoi
Efficacy and toxicity of bimodal radiotherapy in WHO grade 2 meningiomas following subtotal resection with carbon ion boost: Prospective phase 2 MARCIE trial
Neuro-Oncology 2023cited by 18position: middledoi
Analysis of safety and efficacy of proton radiotherapy for IDH-mutated glioma WHO grade 2 and 3
Journal of Neuro-Oncology 2023cited by 17position: firstdoi
Comparison of different dose accumulation strategies to estimate organ doses after stereotactic magnetic resonance-guided adaptive radiotherapy
Radiation Oncology 2023cited by 12position: middledoi
Management of initial and recurrent radiation-induced contrast enhancements following radiotherapy for brain metastases: Clinical and radiological impact of bevacizumab and corticosteroids
Clinical and Translational Radiation Oncology 2023cited by 11position: middledoi
Analysis of recurrence probability following radiotherapy in patients with CNS WHO grade 2 meningioma using integrated molecular-morphologic classification
Neuro-Oncology Advances 2023cited by 10position: middledoi
Oral Sequelae after Head and Neck Radiotherapy: RCT Comparing 3D-Printed Tissue Retraction Devices with Conventional Dental Splints
Journal of Clinical Medicine 2023cited by 7position: middledoi
RADT-40. FINAL RESULTS OF THE PROSPECTIVE PHASE 2 MARCIE TRIAL: EFFICACY AND TOXICITY OF POSTOPERATIVE BIMODAL RADIOTHERAPY WITH C12-BOOST IN PATIENTS WITH ATYPICAL MENINGIOMAS FOLLOWING SUBTOTAL RESECTION
Neuro-Oncology 2023cited by 1position: middledoi
Adaptive MR-Guided Stereotactic Radiotherapy is Beneficial for Ablative Treatment of Lung Tumors in High-Risk Locations
Frontiers in Oncology 2022cited by 37position: middledoi
SMART ablation of lymphatic oligometastases in the pelvis and abdomen: Clinical and dosimetry outcomes
Radiotherapy and Oncology 2022cited by 26position: middledoi
Radiation-induced contrast enhancement following proton radiotherapy for low-grade glioma depends on tumor characteristics and is rarer in children than adults
Radiotherapy and Oncology 2022cited by 24position: firstdoi
Results of a prospective randomized trial on long-term effectiveness of protons and carbon ions in prostate cancer: LEM I and α/β = 2 Gy overestimates the RBE
Radiotherapy and Oncology 2022cited by 14position: firstdoi
Iatrogenic influence on prognosis of radiation-induced contrast enhancements in patients with glioma WHO 1–3 following photon and proton radiotherapy
Radiotherapy and Oncology 2022cited by 14position: firstdoi
Return to Work, Fatigue and Cancer Rehabilitation after Curative Radiotherapy and Radiochemotherapy for Pelvic Gynecologic Cancer
Cancers 2022cited by 12position: middledoi
Secondary Malignancy Risk Following Proton vs. X-ray Radiotherapy of Thymic Epithelial Tumors: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk
Cancers 2022cited by 10position: middledoi
Postoperative Radiotherapy and the Role of Regional Lymph Node Irradiation in Localized Merkel Cell Carcinoma: A Single-Center Retrospective Analysis
Cancers 2022cited by 9position: middledoi
Intensity modulated proton therapy for early-stage glottic cancer: high-precision approach to laryngeal function preservation with exceptional treatment tolerability
Radiation Oncology 2022cited by 6position: middledoi
Effect of timing, technique and molecular features on brain control with local therapies in oncogene-driven lung cancer
ESMO Open 2021cited by 17position: middledoi
Carbon Ion Radiation Therapy: One Decade of Research and Clinical Experience at Heidelberg Ion Beam Therapy Center
International Journal of Radiation Oncology*Biology*Physics 2021cited by 16position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Jürgen Debus · NYU Langone Health35 papers (2020–2024)Laila König · Heidelberg University29 papers (2020–2025)Juliane Hörner‐Rieber · German Cancer Research Center26 papers (2020–2025)Sebastian Regnery · Brigham and Women's Hospital22 papers (2020–2025)Thomas Held · Heidelberg University18 papers (2020–2025)Klaus Herfarth · Universitätsklinik für Strahlentherapie18 papers (2021–2025)Jonathan W. Lischalk · New York University15 papers (2022–2025)Maximilian Deng · Heidelberg University14 papers (2023–2025)Eva Meixner · DKFZ-ZMBH Alliance13 papers (2022–2024)Sebastian Adeberg · Goethe University Frankfurt13 papers (2020–2025)Kristin Lang · Heidelberg University12 papers (2020–2025)Fabian Weykamp · German Cancer Research Center9 papers (2020–2025)Michael Thomas · Barwon Health8 papers (2020–2024)Elisabetta Sandrini · University Hospital Heidelberg8 papers (2022–2024)Rami A. El Shafie · University Medical Center7 papers (2020–2025)Andreas von Deimling · Stiftung Schleswig-Holsteinische Landesmuseen7 papers (2023–2025)Felix Sahm · Heidelberg (Poland)7 papers (2023–2025)Wolfgang Wick · Heidelberger Institut für Radioonkologie7 papers (2023–2025)Philipp Hoegen · German Cancer Research Center6 papers (2022–2023)Semi Harrabi · Heidelberg University6 papers (2021–2023)